| 1 | | {[(benzyloxy)carbonyl]amino}(2,4,6-trimethoxyphenyl)acetic acid | {[(benzyloxy)carbonyl]amino}(2,4,6-trimethoxyphenyl)acetic acid | C19H21NO7 | |
| 2 | 1076198-54-3 | 2-[Methyl-1-(4-methoxyphenyl)methoxy]propyl-4'-nitrophenyl Carbonate | 2-[Methyl-1-(4-methoxyphenyl)methoxy]propyl-4'-nitrophenyl Carbonate | C19H21NO7 | |
| 3 | | 2-[1-[(Benzyloxycarbonyl)amino]-3-oxo-4-hexynyl]malonic acid dimethyl ester | 2-[1-[(Benzyloxycarbonyl)amino]-3-oxo-4-hexynyl]malonic acid dimethyl ester | C19H21NO7 | |
| 4 | | N-Des(cyclopropylMethyl)-N-Methoxycarbonyl-3-O-Methyl 8β-Hydroxy Naltrexone | N-Des(cyclopropylMethyl)-N-Methoxycarbonyl-3-O-Methyl 8β-Hydroxy Naltrexone | C19H21NO7 | Chiral Reagents;Impurities;Intermediates & Fine Chemicals;Pharmaceuticals |
| 5 | | 2-[(1R)-3-Oxo-1-[(4S)-2-oxo-4-phenyloxazolidin-3-yl]-4-pentenyl]malonic acid dimethyl ester | 2-[(1R)-3-Oxo-1-[(4S)-2-oxo-4-phenyloxazolidin-3-yl]-4-pentenyl]malonic acid dimethyl ester | C19H21NO7 | |
| 6 | 1415816-48-6 | 1-OXO-2-(3,4,5-TRIMETHOXYBENZYL)-1,2,3,6,7,7A-HEXAHYDRO-3A,6-EPOXYISOINDOLE-7-CARBOXYLIC ACID | 4-OXO-3-(3,4,5-TRIMETHOXYBENZYL)-10-OXA-3-AZATRICYCLO[5.2.1.0'1,5']DEC-8-ENE-6-CARBOXYLIC ACID
1-OXO-2-(3,4,5-TRIMETHOXYBENZYL)-1,2,3,6,7,7A-HEXAHYDRO-3A,6-EPOXYISOINDOLE-7-CARBOXYLIC ACID | C19H21NO7 | |